UCL Technology Fund logo

UCL Technology Fund

Europe, England, United Kingdom, London

Description

The UCL Technology Fund (UCLTF) is a specialized venture capital fund dedicated to commercializing intellectual property arising from University College London's world-class research base. Managed by AlbionVC, the fund acts as a crucial bridge between groundbreaking academic discoveries and their market application, fostering the creation of new companies and technologies. Its unique mandate positions it at the forefront of deep tech innovation within the United Kingdom, specifically targeting the translation of scientific breakthroughs into tangible economic and societal value.

UCLTF's investment focus spans a broad spectrum of deep technology sectors, including life sciences, physical sciences, engineering, and digital technologies. The fund primarily invests in early-stage UCL spin-outs and start-ups, providing the vital capital and strategic support needed to navigate the complex journey from laboratory to market. By concentrating on opportunities directly emerging from UCL's extensive research, UCLTF ensures a high degree of scientific rigor and proprietary technology at the core of its portfolio companies, addressing critical challenges in various industries.

Typically, UCLTF makes initial investments ranging from approximately $635,000 to $6,350,000, demonstrating its commitment to providing substantial early-stage capital. The fund also possesses the capacity for significant follow-on investments, supporting its portfolio companies through subsequent growth rounds. Launched in 2016 with an initial fund of £50 million, the UCL Technology Fund has since expanded its capacity, with a second fund, UCL Technology Fund 2, targeting £100 million. This growth underscores its sustained commitment to nurturing high-potential ventures.

With a portfolio exceeding 50 companies, UCLTF plays a pivotal role in strengthening the UK's innovation ecosystem. Its strategic investments not only accelerate the development of transformative technologies but also contribute to job creation and economic growth, cementing UCL's position as a powerhouse of commercialization. The fund's long-term vision is to continue translating pioneering research into successful enterprises that deliver significant impact globally.

Investor Profile

UCL Technology Fund has backed more than 38 startups, with 2 new investments in the last 12 months alone. The firm has led 18 rounds, about 47% of its total and boasts 5 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Seed, Series A, Series B rounds (top funding stages).
  • Majority of deals are located in United Kingdom, United States.
  • Strong thematic focus on Biotechnology, Health Care, Software.
  • Typical check size: $635K – $6.3M.

Stage Focus

  • Seed (39%)
  • Series A (29%)
  • Series B (11%)
  • Series Unknown (11%)
  • Pre Seed (8%)
  • Convertible Note (3%)

Country Focus

  • United Kingdom (95%)
  • United States (5%)

Industry Focus

  • Biotechnology
  • Health Care
  • Software
  • Artificial Intelligence (Ai)
  • Machine Learning
  • Manufacturing
  • Information Technology
  • Renewable Energy
  • Therapeutics
  • Semiconductor
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does UCL Technology Fund frequently co-invest with?

AlbionVC
Europe, England, United Kingdom, London
Co-Investments: 6
Clean Growth Fund
Europe, England, United Kingdom, London
Co-Investments: 4
BGF Ventures
Europe, Aberdeen City, United Kingdom, Aberdeen
Co-Investments: 4
London Co-Investment Fund
Europe, England, United Kingdom, London
Co-Investments: 7
UCLB
Europe, England, United Kingdom, London
Co-Investments: 3
F-Prime Capital
North America, Massachusetts, United States, Cambridge
Co-Investments: 3
IP Group
Europe, England, United Kingdom, London
Co-Investments: 4
AI Seed
Europe, England, United Kingdom, London
Co-Investments: 3
Syncona Partners LLP
Europe, England, United Kingdom, London
Co-Investments: 3
Parkwalk Advisors
Europe, England, United Kingdom, London
Co-Investments: 8

Which angels does UCL Technology Fund often collaborate with?

EL
North America, Florida, United States, Miami Beach
Shared Deals: 1
WT
Europe, England, United Kingdom, London
Shared Deals: 1
JY
North America, California, United States, San Francisco
Shared Deals: 1
MB
Europe, Cambridgeshire, United Kingdom, Cambridge
Shared Deals: 1
CS
North America, Washington, United States, Kirkland
Shared Deals: 1
XL
Europe, England, United Kingdom, London
Shared Deals: 1

What are some of recent deals done by UCL Technology Fund?

Oriole Networks

London, England, United Kingdom

Oriole Networks is a startup that speeds up data centers and enhances AI system.

Artificial Intelligence (AI)Communication HardwareCommunications InfrastructureData CenterOptical Communication
Series AOct 21, 2024
Amount Raised: $22,000,000
Gaussion

London, England, United Kingdom

Gaussion develops a novel solution using an external magnetic field to enhance battery performance.

BatteryRenewable EnergySemiconductor
Series AAug 12, 2024
Amount Raised: $11,907,974
EpilepsyGTx

Cambridge, Cambridgeshire, United Kingdom

EpilepsyGTx is a late-stage biotech company exploring cutting-edge gene therapies to improve the management of focal refractory epilepsy.

Biotechnology
SeedJun 24, 2024
Amount Raised: $10,000,000
Oriole Networks

London, England, United Kingdom

Oriole Networks is a new company that improve the performance of AI systems and speed up data centers while lowering energy usage.

Artificial Intelligence (AI)Renewable Energy
SeedMar 27, 2024
Amount Raised: $12,617,500
Stanhope

London, England, United Kingdom

Stanhope creates and delivers major commercial and mixed-use developments in London and the South East.

Property ManagementReal Estate
SeedMar 24, 2024
Amount Raised: $2,300,000
Stanhope AI

London, England, United Kingdom

Stanhope AI instructs machines and robots on how to make decisions in the actual world.

IT Management
SeedMar 20, 2024
Amount Raised: $2,943,529
Echopoint Medical

London, England, United Kingdom

Echopoint Medical is a medtech company

Health CareMedicalMedical Device
Series AFeb 20, 2024
Amount Raised: $5,302,475
Phasecraft

London, England, United Kingdom

Phasecraft is a quantum computing software developer.

ComputerInformation TechnologyQuantum ComputingSoftware
Series AAug 16, 2023
Amount Raised: $16,545,629
Tenpoint Therapeutics

Camborne, Cornwall, United Kingdom

Tenpoint Therapeutics is a biotechnology company pursuing vision-restoring engineered cell-based therapeutics.

BiotechnologyProduct Research
Series AJul 12, 2023
Amount Raised: $70,000,000
Gaussion

London, England, United Kingdom

Gaussion develops a novel solution using an external magnetic field to enhance battery performance.

BatteryRenewable EnergySemiconductor
SeedApr 20, 2023
Amount Raised: $3,545,640